Liu Wei Di Huang
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
HERBAL SUPPORT for CANCER PATIENTS by John Heuertz, DOM
HERBAL SUPPORT FOR CANCER PATIENTS By John Heuertz, DOM One of the most widely studied and accepted uses of Chinese herbs among modern medical treatments is Fu Zheng Pei Ben (FZPB) therapy in adjuvant cancer treatment. “Fu Zheng” re- fers to the support of the body’s normal healthy qi, the “Zheng qi”; “Pei Ben” refers to the stra- tegic reinforcement of the body’s ability to fight specific disease manifestations. When used in combination with proven modern medical treatments for cancer—specifically, chemotherapy, radiotherapy, and surgery—FZPB can minimize clinical side effects and facilitate recovery. This guide is intended to assist qualified licensed Oriental Medicine (OM) practitioners in supporting patients with cancer. Please Note: Though the Materia Medicae of OM lists herbs that can break up masses and herbs which posses anti-neoplastic actions, the formulas discussed in this paper are neither designed nor intended to “cure cancer” per se, nor to be employed as the primary treatment for a patient with can- cer. Use this guide to assist your selection of the right FZPB strategy. Be sure the patient receives regular assessments by a qualified medical doctor. OVERVIEW OF FZPB THERAPY IN THE TREATMENT OF CANCER Oriental Medicine and western medicine agree that cancerous tumors are a localized manifestation of a pathology that exists in the entire body. This pathology can result from exposure to toxins such as radia- tion or carcinogenic chemicals, or owing to exogenous pathogens, a malfunctioning immune system or immunodeficiency, poor nutrition, hereditary tendencies, weakness or damage to the organs, prolonged qi and/or blood stagnation, prolonged blood or yin deficiency, emotional factors, and more. -
The Web That Has No Weaver
THE WEB THAT HAS NO WEAVER Understanding Chinese Medicine “The Web That Has No Weaver opens the great door of understanding to the profoundness of Chinese medicine.” —People’s Daily, Beijing, China “The Web That Has No Weaver with its manifold merits … is a successful introduction to Chinese medicine. We recommend it to our colleagues in China.” —Chinese Journal of Integrated Traditional and Chinese Medicine, Beijing, China “Ted Kaptchuk’s book [has] something for practically everyone . Kaptchuk, himself an extraordinary combination of elements, is a thinker whose writing is more accessible than that of Joseph Needham or Manfred Porkert with no less scholarship. There is more here to think about, chew over, ponder or reflect upon than you are liable to find elsewhere. This may sound like a rave review: it is.” —Journal of Traditional Acupuncture “The Web That Has No Weaver is an encyclopedia of how to tell from the Eastern perspective ‘what is wrong.’” —Larry Dossey, author of Space, Time, and Medicine “Valuable as a compendium of traditional Chinese medical doctrine.” —Joseph Needham, author of Science and Civilization in China “The only approximation for authenticity is The Barefoot Doctor’s Manual, and this will take readers much further.” —The Kirkus Reviews “Kaptchuk has become a lyricist for the art of healing. And the more he tells us about traditional Chinese medicine, the more clearly we see the link between philosophy, art, and the physician’s craft.” —Houston Chronicle “Ted Kaptchuk’s book was inspirational in the development of my acupuncture practice and gave me a deep understanding of traditional Chinese medicine. -
Nine Traditional Chinese Herbal Formulas for the Treatment of Depression: an Ethnopharmacology, Phytochemistry, and Pharmacology Review
Journal name: Neuropsychiatric Disease and Treatment Article Designation: Review Year: 2016 Volume: 12 Neuropsychiatric Disease and Treatment Dovepress Running head verso: Feng et al Running head recto: Chinese herbal formulas as antidepressants open access to scientific and medical research DOI: http://dx.doi.org/10.2147/NDT.S114560 Open Access Full Text Article REVIEW Nine traditional Chinese herbal formulas for the treatment of depression: an ethnopharmacology, phytochemistry, and pharmacology review Dan-dan Feng Abstract: Depression is a major mental disorder, and is currently recognized as the Tao Tang second-leading cause of disability worldwide. However, the therapeutic effect of antidepressants Xiang-ping Lin remains unsatisfactory. For centuries, Chinese herbal formulas (CHFs) have been widely used in Zhao-yu Yang the treatment of depression, achieving better therapeutic effects than placebo and having fewer Shu Yang side effects than conventional antidepressants. Here, we review the ethnopharmacology, phy- Zi-an Xia tochemistry, and pharmacology studies of nine common CHFs: “banxia houpo” decoction, “chaihu shugansan”, “ganmaidazao” decoction, “kaixinsan”, “shuganjieyu” capsules, “sinisan”, Yun Wang “wuling” capsules, “xiaoyaosan”, and “yueju”. Eight clinical trials and seven meta-analyses have Piao Zheng supported the theory that CHFs are effective treatments for depression, decreasing Hamilton Yang Wang Depression Scale scores and showing few adverse effects. Evidence from 75 preclinical studies Chun-hu Zhang has also elucidated the multitarget and multipathway mechanisms underlying the antidepres- Laboratory of Ethnopharmacology, sant effect of the nine CHFs. Decoctions, capsules, and pills all showed antidepressant effects, Institute of Integrated Traditional ranked in descending order of efficacy. According to traditional Chinese medicine theory, these Chinese and Western Medicine, Xiangya Hospital, Central South CHFs have flexible compatibility and mainly act by soothing the liver and relieving depression. -
Investigation of China's Yunnan Pharmaceutical Industry Derived from Two Ethnomedicines, Yi Medicine and Dai Medicine
Investigation of China’s Yunnan pharmaceutical industry derived from two ethnomedicines, Yi medicine and Dai medicine Zhiyong Li Kunming University of Science and Technology Caifeng Li Jiangxi University of Traditional Chinese Medicine Xiaobo Zhang China Academy of Chinese Medical Sciences Shihuan Tang China Academy of Chinese Medical Sciences Xiulan Huang Minzu University of China Hongjun Yang China Academy of Chinese Medical Sciences Xiuming Cui Kunming University of Science and Technology Luqi Huang ( [email protected] ) Research Keywords: Ethnomedicine; Dai patent medicine; Yi patent medicine; Ethnic Pharmaceutical Industry; Traditional knowledge Posted Date: January 22nd, 2020 DOI: https://doi.org/10.21203/rs.2.21598/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/21 Abstract Background: Yunnan Province is a multi-ethnic area located in the southwest of China, and she also is rich in Chinese matiera medica resources, known as the ‘kingdom of plants’. There is abundant of ethnomedicine resources in Yunnan province and many ethnic minorities inherit and retain numerous knowledge of traditional medicine. The biomedicine and big health industry have been the pillar industry of Yunnan since 2016, which is the important pharmaceutical industrial base for Dai Medicine and Yi Medicine in China, for example Yunnan Baiyao with “amazing ecacy” and originating from a Yi medical formula. Yi medicine and Dai medicine of Yunnan Province were investigated in this work focusing on the basic information of Dai patent medicine (DPM) and Yi patent medicine (YPM), including the clinical indications, herbal resources and their sources of traditional knowledge. -
Traditional Chinese Medicine
中醫 施今墨對藥 中醫基礎 中西醫結合 Traditional Chinese Medicine SHI JIN MO DUI YAO 5 TCM Principles Integrated Traditional & 2 Multiple Sclerosis (MS) - A 5 Art of Combining Western Medicine Chinese Medicine Perspective Medicinals According to 7 Getting Results in Multiple Master Shi Jin Mo Sclerosis Management 研究 質量 安全 Research, Quality, safty and Efficacy CONTENTS 10 Sun Ten Ginseng-Premium six Years Old Ginseng 中醫 TRADITIONAL CHINESE MEDICINE Multiple Sclerosis (MS) – A Chinese Medicine Perspective Signs and Symptoms nourish kidney and liver yin, transform • Weakness and loss of muscle phlegm and move blood. • co-ordination Over time, kidney yin vacuity is likely to • Tingling, numbness, dizziness change into a vacuity of both yin and yang. • Blurred vision Thus, herbs are added that supplement • Pain yang. Also, more stasis moving herbs may • Heat sensitivity be needed, including herbs that move liver • Loss of bladder control qi. As stasis may transform into heat, heat • Memory loss, problem-solving clearing herbs may also be added. difficulties • Mood disturbances Theory behind the symptoms The liver stores blood and opens at the eyes; hence there is a strong connection Multiple sclerosis (MS) is an unpredictable Western Drug Therapies between the state of the liver and the state disease of the nervous system in which Your patient may already take the following of the eyes. Liver yin/blood vacuity may communication between the brain and Western Medication: impair vision. other parts of the body is disrupted. Its • Steroids with anti-inflammatory effects can range from relatively mild properties (e.g. prednisone) to reduce Blood and yin deficiency may give rise to devastating. -
SC62 Doc. 47.2, Annex (Rev
SC62 Doc. 47.2 Annex (Rev. 2) Species trade and conservation Rhinoceroses Assessment of Rhino Horn as a Traditional Medicine A report prepared for the CITES Secretariat by Kristin Nowell on behalf of TRAFFIC* April 2012 Executive Summary Pursuant to CITES Project No. S-389, the Secretariat concluded a contract with TRAFFIC in March 2012 to produce an overview report summarizing relevant information on the current usages of rhinoceros horn. This work was completed in April 2012 for consideration at the 62nd meeting of the Standing Committee (SC62). This report was supported by funding from DEFRA- Department for Environment, Food and Rural Affairs-UK. This report is based on a literature review and information collected by non-governmental organizations (particularly TRAFFIC offices in East and Southeast Asia), and focuses on five historical consumer markets where both domestic and international trade in rhino horn is prohibited or controlled: China, Taiwan (Province of China), Japan, the Republic of Korea and Viet Nam. These five were selected based on a preliminary evaluation of available information as having strong traditions of medicinal use of rhino horn and varying experiences under existing rhino horn trade controls. Structure and composition of rhino horn Rhino horn grows in layers from specialized skin cells in layers, which are keratinized (invaded by keratin proteins) and become hard and inert, with all cellular function ceasing. Rhino horn lacks a bony core and is composed entirely of hard keratin proteins, of a type (the alpha keratins) common to most mammals. Rhino horn is similar, but not identical, in chemical composition to water buffalo, cattle and yak horns, which are frequently used to substitute for rhino horn in traditional medicinal formulas. -
Traditional Chinese Medicine—–What Are We Investigating? the Case of Menopauseଝ
Complementary Therapies in Medicine (2007) 15, 54—68 Traditional Chinese medicine—–What are we investigating? The case of menopauseଝ Volker Scheid ∗ School of Integrated Health, University of Westminster, 115 New Cavendish Street, Westminster, London W1W 6UW, United Kingdom Available online 9 February 2006 KEYWORDS Summary CAM researchers commonly treat traditional medicines as unchang- Traditional Chinese ing systems. This article questions the validity of this approach by examining the medicine; treatment of menopausal syndrome by traditional Chinese medicine (TCM). Such Kampo; treatment strategies were invented in 1964 and betray a strong influence of biomed- Traditional medicine; ical thinking. While they determine TCM treatment of menopausal syndrome in the Menopause; West, physicians in China and Japan use many other treatment strategies from within the wider Chinese medical tradition in clinical practice. Cultural variability in the Research design; manifestation of menopausal syndrome furthermore questions the usefulness of sim- Medical anthropology; ply importing treatment strategies from China to the West. This leads me to conclude History of medicine that Chinese medicine as such can never be evaluated by means of clinical research. What we can do is use Chinese medicine as a resource for thinking about illness, and for formulating clinical interventions that may then be assessed using methods of evidence based research. © 2006 Published by Elsevier Ltd. Introduction ous efforts to find alternatives. This specifically includes the integration of complementary and Eighty percent of women in the UK experience alternative medicines (CAM) into treatment proto- menopausal symptoms and 45% find the symp- cols tailored to women’s individual needs.1—3 toms distressing.1 An increasing awareness among Traditional Chinese medicine (TCM) appears to both health care providers and patients regarding be a fruitful area to which such efforts might be potential adverse effects associated with hormone directed. -
Research Article Chinese Patent Medicine Liu Wei Di
Hindawi Publishing Corporation Evidence-Based Complementary and Alternative Medicine Volume 2012, Article ID 714805, 7 pages doi:10.1155/2012/714805 Research Article Chinese Patent Medicine Liu Wei Di Huang Wan Combined with Antihypertensive Drugs, a New Integrative Medicine Therapy, for the Treatment of Essential Hypertension: A Systematic Review of Randomized Controlled Trials Jie Wang,1 Kuiwu Yao,1 Xiaochen Yang,1 Wei Liu, 1 Bo Feng,1 Jizheng Ma,2 Xinliang Du,3 Pengqian Wang,4 and Xingjiang Xiong1 1 Department of Cardiology, Guanganmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China 2 Department of Gastroenterology, Guanganmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China 3 Graduate School, China Academy of Chinese Medical Sciences, Beijing 100700, China 4 Department of Endocrinology, Traditional Chinese Medicine Hospital of Mentougou District, Beijing 102300, China Correspondence should be addressed to Xingjiang Xiong, [email protected] Received 26 August 2012; Accepted 10 October 2012 Academic Editor: Vassya Bankova Copyright © 2012 Jie Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Objectives. To assess the beneficial and adverse effects of Liu Wei Di Huang Wan (LWDHW), combined with antihypertensive drugs, for essential hypertension. Methods. Five major electronic databases were searched up to August 2012 to retrieve any potential randomized controlled trials designed to evaluate the clinical effectiveness of LWDHW combined with antihypertensive drugs for essential hypertension reported in any language, with main outcome measures as blood pressure. -
View a Copy of This Licence, Visit
Yu et al. The Journal of Headache and Pain (2020) 21:53 The Journal of Headache https://doi.org/10.1186/s10194-020-01117-2 and Pain RESEARCH ARTICLE Open Access Migraine treatment and healthcare costs: retrospective analysis of the China Health Insurance Research Association (CHIRA) database Shengyuan Yu1, Yanlei Zhang2*, Yuan Yao2 and Haijun Cao2 Abstract Background: Adult migraine remains underdiagnosed and undertreated, despite significant negative effects on physical and emotional functioning. Information on prescribing patterns and treatment costs of migraine in China is limited. Methods: This retrospective analysis of the China Health Insurance Research Association (CHIRA) medical insurance claims database in 2016 to 2017 evaluated treatment patterns, direct medical costs, and healthcare resource utilization among adults with migraine in mainland China. Results: Of 108,375 patients with headache-related outpatient visits, 10,652 were adults with migraine (mean age 51.4 years, 55.4% female). Common comorbidities were major depressive disorder (4.1%), insomnia (3.8%), and anxiety (2.3%). Migraine patients were prescribed acute medication (26.4%), preventive medication (15.0%), and Chinese patent and herbal medicines (24.5% and 11.7%, respectively). Of patients prescribed acute medication, 68.8% received non-aspirin non-steroidal anti-inflammatory drugs (NSAIDs), 7.1% received opioids, while only 3.3% received triptans. Mean annual outpatient costs per patient were 46.5 United States dollars (USD), with mean (standard deviation) 1.8 (2.0) outpatient visits per year. Medication costs for traditional Chinese medicine (22.4 USD per patient) were higher than for Western medicine (13.5 USD). Conclusion: Among migraine patients in China, NSAIDs were commonly prescribed as acute medication, while utilization of migraine-specific triptans and preventive medications was low. -
Kan Herbals Formula Guide
FORMULA GUIDE Chinese Herbal Products You Can Trust Kan Herbals – Formulas by Ted Kaptchuk, O.M.D. Written and researched by Ted J. Kaptchuk, O.M.D.; Z’ev Rosenberg, L.Ac. Copyright © 1992 by Sanders Enterprises with revisions of text and formatting by Kan Herb Company. Copyright © 1996 by Andrew Miller with revisions of text and formatting by Kan Herb Company. Copyright © 2008 by Lise Groleau with revisions of text and formatting by Kan Herb Company. All rights reserved. No part of this written material may be reproduced or stored in any retrieval system, by any means – photocopy, electronic, mechanical or otherwise – for use other than “fair use,” without written consent from the publisher. Published by Golden Mirror Press, California. Printed in the United States of America. First Edition, June 1986 Revised Edition, October 1988 Revised Edition, May 1992 Revised Edition, November 1994 Revised Edition, April 1996 Revised Edition, January 1997 Revised Edition, April 1997 Revised Edition, July 1998 Revised Edition, June 1999 Revised Edition, June 2002 Revised Edition, July 2008 Revised Edition, February 2014 Revised Edition, January 2016 FORMULA GUIDE 25 Classical Chinese Herbal Formulas Adapted by Ted Kaptchuk, OMD, LAc Contents Product Information.....................................................................................................................................1 Certificate of Analysis Sample .................................................................................................................6 High Performance -
Efficacy and Safety of Lian-Ju-Gan-Mao
Wang et al. Trials (2017) 18:2 DOI 10.1186/s13063-016-1747-9 STUDY PROTOCOL Open Access Efficacy and safety of Lian-Ju-Gan-Mao capsules for treating the common cold with wind-heat syndrome: study protocol for a randomized controlled trial Shengjun Wang1, Hongli Jiang1*, Qin Yu2, Bin She1 and Bing Mao1* Abstract Background: The common cold is a common and frequent respiratory disease mainly caused by viral infection of the upper respiratory tract. Chinese herbal medicine has been increasingly prescribed to treat the common cold; however, there is a lack of evidence to support the wide utility of this regimen. This protocol describes an ongoing phase II randomized controlled clinical trial, based on the theory of traditional Chinese medicine (TCM), with the objective of evaluating the efficacy and safety of Lian-Ju-Gan-Mao capsules (LJGMC), a Chinese patent medicine, compared with placebo in patients suffering from the common cold with wind-heat syndrome (CCWHS). Methods/design: This is a multicenter, randomized, double-blind, placebo-controlled phase II clinical trial. A total of 240 patients will be recruited and randomly assigned to a high-dose group, medium-dose group, low-dose group, and placebo-matched group in a 1:1:1:1 ratio. The treatment course is 3 consecutive days, with a 5-day follow-up. The primary outcome is time to all symptoms’ clearance. Secondary outcomes include time to the disappearance of primary symptoms and each secondary symptom, time to fever relief, time to fever clearance, and change in TCM symptom and sign scores. Discussion: This trial is a well-designed study according to principles and regulations issued by the China Food and Drug Administration (CFDA). -
Understanding Traditional Chinese Medicine – a Doctor's Viewpoint
Review Article Singapore Med J 2001 Vol 42(10) : 487-492 Understanding Traditional Chinese Medicine – A Doctor’s Viewpoint N K Ho ABSTRACT mainstream medicine. Some call it Western Medicine. Generally modern medicine practitioners (doctors) Singapore is a cosmopolitan country and its 1a are trained in the universities, medical schools population comprises the Chinese, Malays, Indians, and hospitals where they are taught basic medical and others such as the Eurasians. In this heteroge- sciences and clinical skills. Modern medicine is neous, multi-racial, multi-lingual and multi-cultural also known in US as conventional medicine. society, medical treatment is also varied. People can seek modern (mainstream, western) medicine or 2. CAM or complementary and alternative medicine traditional medicine when they are sick. Usually they The term “complementary and alternative medicine” first seek modern medicine. Some turn to tradi- (CAM) reflects the nature of treatment that it tional medicine as complementary treatment or complements modern medicine, or used as an alternative treatment. Traditional medicine is alternative(1,2). CAM is not recognised as the here to stay in this country. In November 2000, the dominant medical system (main stream). Therefore Traditional Chinese Medicine (TCM) Practitioners 1bit is not available in hospitals, or reimbursable by Bill was passed in the Singapore Parliament. health insurance companies, the employers and Health care providers, including doctors, would others. Professional practice registration is usually benefit from a good knowledge of both modern and not required and a monitoring organisation or traditional medicine. Practitioners in traditional independent audit systems are usually lacking. medicine should also learn modern medicine.